telmisartan has been researched along with Left Ventricular Dysfunction in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (40.00) | 29.6817 |
2010's | 6 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Agostoni, P; Bilo, G; Branzi, G; Ciambellotti, F; Faini, A; Giuliano, A; Gregorini, F; Lombardi, C; Malfatto, G; Mancia, G; Osculati, G; Parati, G; Revera, M | 1 |
Bal, UA; Baysal, SS; Müderrisoğlu, H; Okyay, K; Öztuna, D; Pirat, B; Uluçam, MZ | 1 |
Anderson, C; Cowan, BR; Doughty, RN; Jennings, GL; Krittayaphong, R; Lonn, E; Marwick, TH; Reid, CM; Sanderson, JE; Schmieder, RE; Teo, K; Wadham, AK; Worthley, SG; Young, AA; Yu, CM; Yusuf, S | 2 |
Mordovina, AG; Morozova, OI; Pozdniakova, NV; Sekerko, SA; Tatarchenko, IP | 1 |
Iuchi, A; Miyoshi, H; Mizuguchi, Y; Nagase, N; Oishi, Y; Oki, T | 1 |
Hara, Y; Hoshino, Y; Kosaka, N; Okada, M; Yamawaki, H | 1 |
Cadeddu, C; Deidda, M; Dessì, M; Madeddu, C; Mantovani, G; Massa, E; Mercuro, G; Piras, A | 1 |
Goto, SN; Iwata, K; Mizuno, Y; Takagi, H; Umemoto, T | 1 |
Yusuf, S | 1 |
2 review(s) available for telmisartan and Left Ventricular Dysfunction
Article | Year |
---|---|
Blood pressure-independent effects of telmisartan on regression of left ventricular mass: a meta-analysis and meta-regression of randomized controlled trials.
Topics: Angiotensin Receptor Antagonists; Benzimidazoles; Benzoates; Blood Pressure; Humans; Randomized Controlled Trials as Topic; Regression Analysis; Telmisartan; Treatment Outcome; Ventricular Dysfunction, Left | 2013 |
From the HOPE to the ONTARGET and the TRANSCEND studies: challenges in improving prognosis.
Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cardiovascular Diseases; Carotid Artery Diseases; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Prognosis; Ramipril; Receptor, Angiotensin, Type 1; Telmisartan; Treatment Outcome; Ultrasonography; Ventricular Dysfunction, Left | 2002 |
6 trial(s) available for telmisartan and Left Ventricular Dysfunction
Article | Year |
---|---|
Effects of hypobaric hypoxia exposure at high altitude on left ventricular twist in healthy subjects: data from HIGHCARE study on Mount Everest.
Topics: Adult; Aged; Altitude; Altitude Sickness; Analysis of Variance; Benzimidazoles; Benzoates; Double-Blind Method; Drug Administration Schedule; Echocardiography, Doppler; Female; Follow-Up Studies; Healthy Volunteers; Humans; Hypoxia; Image Interpretation, Computer-Assisted; Male; Middle Aged; Oxygen Consumption; Reference Values; Telmisartan; Ventricular Dysfunction, Left | 2016 |
Treatment-associated change in apelin concentration in patients with hypertension and its relationship with left ventricular diastolic function.
Topics: Amlodipine; Antihypertensive Agents; Apelin; Biomarkers; Case-Control Studies; Echocardiography; Female; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Telmisartan; Treatment Outcome; Ventricular Dysfunction, Left | 2017 |
The cardiac MRI substudy to ongoing telmisartan alone and in combination with ramipril global endpoint trial/telmisartan randomized assessment study in ACE-intolerant subjects with cardiovascular disease: analysis protocol and baseline characteristics.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cardiovascular Diseases; Clinical Protocols; Double-Blind Method; Drug Therapy, Combination; Female; Heart Ventricles; Humans; Magnetic Resonance Imaging; Male; Prospective Studies; Quality Control; Ramipril; Reproducibility of Results; Retrospective Studies; Stroke Volume; Telmisartan; Treatment Outcome; Ventricular Dysfunction, Left | 2009 |
Left ventricular mass and volume with telmisartan, ramipril, or combination in patients with previous atherosclerotic events or with diabetes mellitus (from the ONgoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial [ONTARGET]).
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Atherosclerosis; Benzimidazoles; Benzoates; Diabetes Complications; Drug Therapy, Combination; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Magnetic Resonance Imaging; Male; Ramipril; Survival Analysis; Telmisartan; Treatment Outcome; Ventricular Dysfunction, Left | 2009 |
Telmisartan improves morphologic and functional changes in both left ventricular myocardium and carotid arterial wall in patients with hypertension: assessment by tissue Doppler imaging and carotid ultrasonography.
Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Carotid Arteries; Elasticity Imaging Techniques; Female; Humans; Hypertension; Male; Middle Aged; Telmisartan; Treatment Outcome; Ventricular Dysfunction, Left | 2010 |
Protective effects of the angiotensin II receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress, and early ventricular impairment.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Antibiotics, Antineoplastic; Benzimidazoles; Benzoates; Cytokines; Echocardiography, Doppler; Epirubicin; Female; Heart; Humans; Inflammation; Inflammation Mediators; Male; Middle Aged; Myocardial Contraction; Oxidative Stress; Renin-Angiotensin System; Systole; Telmisartan; Ventricular Dysfunction, Left | 2010 |
2 other study(ies) available for telmisartan and Left Ventricular Dysfunction
Article | Year |
---|---|
[Arterial hypertension and type 2 diabetes mellitus: clinical evaluation of hemodynamic characteristics, possibility of correction].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Glucose; Blood Pressure Monitoring, Ambulatory; Diabetes Mellitus, Type 2; Diastole; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enalapril; Female; Follow-Up Studies; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Myocardial Contraction; Telmisartan; Treatment Outcome; Ultrasonography; Ventricular Dysfunction, Left | 2009 |
Effects of captopril and telmisartan on matrix metalloproteinase-2 and -9 expressions and development of left ventricular fibrosis induced by isoprenaline in rats.
Topics: Animals; Benzimidazoles; Benzoates; Captopril; Drug Therapy, Combination; Fibrosis; Gene Expression Regulation, Enzymologic; Isoproterenol; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Random Allocation; Rats; Rats, Wistar; Telmisartan; Ventricular Dysfunction, Left | 2010 |